Identification of a novel immune-inflammatory signature of COVID-19 infections, and evaluation of pharmacokinetics and therapeutic potential of RXn-02, a novel small-molecule derivative of quinolone

Coronavirus disease 2019 (COVID-19) is a global pandemic and respiratory infection that has enormous damage to human lives and economies. It is caused by SARS-CoV-2 (severe acute respiratory syndrome coronavirus 2), a non-pair-stranded positive-sense RNA virus. With increasing global threats and few...

Descripción completa

Detalles Bibliográficos
Autores principales: Lawal, Bashir, Kuo, Yu-Cheng, Rachmawati Sumitra, Maryam, Wu, Alexander T.H., Huang, Hsu-Shan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: The Authors. Published by Elsevier Ltd. 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9272679/
https://www.ncbi.nlm.nih.gov/pubmed/35841781
http://dx.doi.org/10.1016/j.compbiomed.2022.105814

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9272679/
https://www.ncbi.nlm.nih.gov/pubmed/35841781
http://dx.doi.org/10.1016/j.compbiomed.2022.105814

Ejemplares similares